Loading...
XETRMAK
Market cap30mUSD
Dec 23, Last price  
1.41EUR
1D
1.44%
1Q
-17.54%
Jan 2017
11.90%
Name

MATERNUS-Kliniken AG

Chart & Performance

D1W1MN
XETR:MAK chart
P/E
P/S
0.29
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
Rev. gr., 5y
-3.82%
Revenues
102m
-4.12%
106,405,000109,812,000112,797,000111,811,000110,904,000113,942,000113,566,000122,041,000123,269,000124,040,000127,143,000124,278,000124,430,000114,299,000111,437,000106,697,000102,306,000
Net income
-14m
L+1.28%
-4,277,000-2,742,000886,0001,979,000-1,888,000-8,599,000-12,725,00026,844,0002,358,0001,104,000-1,456,000-1,575,000-10,256,000-9,622,000-2,485,000-14,077,000-14,257,000
CFO
3m
-41.70%
3,802,000-5,103,0003,228,0001,853,0005,546,0004,382,0003,068,00011,303,000-2,906,0007,902,0006,922,0006,234,00016,030,00012,167,00017,244,0004,329,0002,524,000
Dividend
Aug 31, 20000.38 EUR/sh
Earnings
Jun 26, 2025

Profile

Maternus-Kliniken Aktiengesellschaft operates retirement and nursing homes, rehabilitation clinics, and various service companies that operate in the field of geriatric care and rehabilitation medicine. The company also provides emergency call, assisted living, rehabilitation, and follow-up treatment services, as well as domestic, inpatient, short term, and handicapped care services. It operates approximately 23 facilities in Germany. The company was founded in 1877 and is headquartered in Berlin, Germany.
IPO date
Apr 02, 1997
Employees
Domiciled in
DE
Incorporated in
DE

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
102,306
-4.12%
106,697
-4.25%
111,437
-2.50%
Cost of revenue
103,738
22,680
16,985
Unusual Expense (Income)
NOPBT
(1,432)
84,017
94,452
NOPBT Margin
78.74%
84.76%
Operating Taxes
1,674
1,251
521
Tax Rate
1.49%
0.55%
NOPAT
(3,106)
82,766
93,931
Net income
(14,257)
1.28%
(14,077)
466.48%
(2,485)
-74.17%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
6,468
36,791
30,533
Long-term debt
163,919
196,751
207,302
Deferred revenue
Other long-term liabilities
22,805
2,512
7,535
Net debt
161,172
231,098
224,958
Cash flow
Cash from operating activities
2,524
4,329
17,244
CAPEX
(3,964)
(2,003)
(1,925)
Cash from investing activities
(3,964)
(2,001)
(1,917)
Cash from financing activities
7,457
(12,761)
(12,792)
FCF
46,216
92,595
109,051
Balance
Cash
8,051
5,196
13,578
Long term investments
1,164
(2,752)
(701)
Excess cash
4,100
7,305
Stockholders' equity
(55,881)
(37,550)
(23,845)
Invested Capital
138,921
170,581
171,607
ROIC
48.37%
52.88%
ROCE
63.00%
63.92%
EV
Common stock shares outstanding
20,970
20,970
20,970
Price
2.82
 
4.70
14.63%
Market cap
59,135
 
98,559
14.63%
EV
221,949
327,519
EBITDA
8,313
95,032
105,569
EV/EBITDA
26.70
3.10
Interest
7,553
5,776
6,010
Interest/NOPBT
6.87%
6.36%